Thyroid diseases during pregnancy: A number of important issues

Hormones

Volumn 14, Issue 1, 2015, Pages 59-69

  Krassas, Gerasimos ^a   Karras, Spyridon N ^b   Pontikides, Nikolaos ^b  

^a Cultural and Educational Center G and H Krassas   (Greece)

^b St Paul's Hospital   (Greece)

Author keywords

Autoimmune thyroiditis; Hyperthyroidism; Hypothyroidism; Pregnancy; Screening during pregnancy; Thyroid disease

Indexed keywords

ANTITHYROID AGENT; CARBIMAZOLE; CHORIONIC GONADOTROPIN; IMMUNOGLOBULIN; LIOTHYRONINE; PROPYLTHIOURACIL; THIAMAZOLE; THYROID ANTIBODY; THYROID HORMONE; THYROID PEROXIDASE; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE;

ACADEMIC ACHIEVEMENT; ATTENTION; AUTOIMMUNE THYROID DISEASE; AUTOIMMUNITY; CHOANA ATRESIA; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; DISEASE DURATION; DRUG CONTRAINDICATION; DRUG COST; DRUG MEGADOSE; ESOPHAGUS ATRESIA; FERTILIZATION IN VITRO; FETUS DISEASE; FETUS MALFORMATION; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; GRAVES DISEASE; HEART RATE; HIGH RISK PREGNANCY; HORMONE RELEASE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; INCIDENCE; INFANT DISEASE; INTELLIGENCE; INTELLIGENCE QUOTIENT; ISOLATED HYPOTHYROXINEMIA; LANGUAGE; LIVER FAILURE; LIVER TOXICITY; LOGISTIC REGRESSION ANALYSIS; LOW BIRTH WEIGHT; LOW DRUG DOSE; MATERNAL DISEASE; MOTOR PERFORMANCE; NEUROPSYCHOLOGICAL TEST; NEWBORN DISEASE; OVERT HYPOTHYROIDISM; PATIENT MONITORING; PRACTICE GUIDELINE; PREDICTIVE VALUE; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PREVALENCE; QUALITY ADJUSTED LIFE YEAR; READING; RETROSPECTIVE STUDY; REVIEW; SCREENING TEST; SENSITIVITY ANALYSIS; SPONTANEOUS ABORTION; STILLBIRTH; SUBCLINICAL HYPOTHYROIDISM; THYROID CRISIS; THYROID DISEASE; THYROID FUNCTION; THYROID FUNCTION TEST; THYROID WEIGHT; THYROIDECTOMY; THYROTOXICOSIS; THYROTROPIN BLOOD LEVEL; TRANSIENT GESTATIONAL HYPERTHYROIDISM SYNDROME; VISION; WEIGHT GAIN; ABORTION, SPONTANEOUS; COMPLICATION; FEMALE; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATIONS; THYROID DISEASES; THYROID GLAND;

ABORTION, SPONTANEOUS; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, FIRST; THYROID DISEASES; THYROID GLAND;

EID: 84927607373     PISSN: 11093099     EISSN: 25208721     Source Type: Journal    
DOI: 10.1007/bf03401381     Document Type: Review

References (73)

1. Vanderpump M, 2014 Thyroid and iodine nutritional status: a UK perspective. Clin Med 14: Suppl 6: s7-s11.
2. Zimmermann MB, 2009 Iodine deficiency. Endocr Rev 30: 376-408.
3. Glinoer D, 1997 Regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev 18: 404-433.
4. Krassas GE, Poppe K, Glinoer D, 2010 Thyroid function and human reproductive health. Endocr Rev 31: 702-755.
5. Abalovich M, Amino N, Barbour LA, et al, 2007 Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 92: S1-S47.
6. Krassas GE, Perros P, Kaprara A, 2008 Thyroid autoimmunity, infertility and miscarriage. Expert Rev Endocrinol Metab 3: 127-136.
7. Kaprara A, Krassas GE, 2008 Thyroid autoimmunity and miscarriage. Hormones (Athens) 7: 294-302.
8. Glinoer D 2005 Thyroid disease during pregnancy. In: Braverman L, Utiger R, eds. Werner’s and Ingbar’s the thyroid: a fundamental and clinical text. 9th ed, Lippincott Williams & Wilkins, Philadelphia; pp; 1086-1108.
9. Glinoer D, 2007 The importance of iodine nutrition during pregnancy. Public Health Nutr 10: 1542-1546.
10. Tortosa F, 2011 Subclinical thyroid dysfunction in pregnancy. Endocrinología y Nutrición 58: 255-257.
11. Glinoer D, Spencer CA, 2010 Serum TSH determinations in pregnancy: how, when and why? Nat Rev Endocrinol 6: 526-529.
12. Anckaert E, Poppe K, Van Uytfanghe K, Schiettecatte J, Foulon W, Thienpont LM, 2010 FT4 immunoassays may display a pattern during pregnancy similar to the equilibrium dialysis ID–LC/tandem MS candidate reference measurement procedure in spite of susceptibility towards binding protein alterations. Clinica Chimica Acta 411: 1348-1353.
13. Kahric-Janicic N, Soldin SJ, Soldin OP, West T, Gu J, Jonklaas J, 2007 Tandem mass spectrometry improves the accuracy of free thyroxine measurements during pregnancy. Thyroid 17: 303-311.
14. Mandel SJ, Spencer CA, Hollowell JG, 2005 Are detection and treatment of thyroid insufficiency in pregnancy feasible? Thyroid 15: 44-53.
15. Midgley JE, Hoermann R, 2013 Measurement of total rather than free thyroxine in pregnancy: the diagnostic implications. Thyroid 23: 259-261.
16. Lee RH, Spencer CA, Mestman JH, et al, 2009 Free T4 immunoassays are flawed during pregnancy. Am J Obstet Gynecol 200: 260-266.
17. Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro-Green A, 2010 Increased pregnancy loss rate in thyroid antibody negative women with TSH levels between 2.5 and 5.0 in the first trimester of pregnancy. J Clin Endocrinol Metab 95: E44-E48.
18. Glinoer D, de Nayer P, Bourdoux P, et al, 1990 Regulation of maternal thyroid during pregnancy. J Clin Endocrinol Metab 71: 276-287.
19. Morreale de Escobar G, Obregón MJ, Escobar del Rey F, 2000 Is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia? J Clin Endocrinol Metab 85: 3975-3987.
20. Patil-Sisodia K, Mestman JH, 2010 Graves hyperthyroidism and pregnancy: a clinical update. Endocr Pract 16: 118-129.
21. Goodwin TM, Montoro M, Mestman JH, Pekary AE, Hershman JM, 1992 The role of chorionic gonadotropin in transient hyperthyroidism of hyperemesis gravidarum. J Clin Endocrinol Metab 75: 1333-1337.
22. LeBeau SO, Mandel SJ, 2006 Thyroid disorders during pregnancy. Endocrinol Metab Clin North Am35: 117-136, vii.
23. Mestman JH, 1997 Hyperthyroidism in pregnancy. Clin Obstet Gynecol 40: 45-64.
24. Mestman JH, 2004 Hyperthyroidism in pregnancy. Best Pract Res Clin Endocrinol Metab 18: 267-288.
25. Davis LE, Lucas MJ, Hankins GD, Roark ML, Cunningham FG, 1989 Thyrotoxicosis complicating pregnancy. Am J Obstet Gynecol 160: 63-70.
26. Millar LK, Wing DA, Leung AS, Koonings PP, Montoro MN, Mestman JH, 1994 Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstet Gynecol 84: 946-949.
27. Phoojaroenchanachai M, Sriussadaporn S, Peerapatdit T, et al, 2001 Effect of maternal hyperthyroidism during late pregnancy on the risk of neonatal low birth weight. Clin Endocrinol (Oxf) 54: 365-370.
28. Sheffield JS, Cunningham FG, 2004 Thyrotoxicosis and heart failure that complicate pregnancy. Am J Obstet Gynecol 190: 211-217.
29. Smith C, Thomsett M, Choong C, Rodda C, McIntyre HD, Cotterill AM, 2001 Congenital thyrotoxicosis in premature infants. Clin Endocrinol (Oxf) 54: 371-376.
30. Haddow JE, Knight GJ, Palomaki GE, McClain MR, Pulkkinen AJ, 2004 The reference range and withinperson variability of thyroid stimulating hormone during the first and second trimesters of pregnancy. J Med Screen 11: 170-174.
31. Chan GW, Mandel SJ, 2007 Therapy insight: management of Graves’ disease during pregnancy. Nat Clin Pract Endocrinol Metab 3: 470-478.
32. Momotani N, Ito K, 1991 Treatment of pregnant patients with Basedow’s disease. Exp Clin Endocrinol 97: 268-274.
33. Mandel SJ, Cooper DS, 2001 The use of antithyroid drugs in pregnancy and lactation. J Clin Endocrinol Metab 86: 2354-2359.
34. Clementi M, Di Gianantonio E, Pelo E, Mammi I, Basile RT, Tenconi R, 1999 Methimazole embryopathy: delineation of the phenotype. Am J Med Genet 83: 43-46.
35. Bournaud C, Orgiazzi J, 2003 Antithyroid agents and embryopathies. Ann Endocrinol (Paris) 64: 366-369.
36. Wolf D, Foulds N, Daya H, 2006 Antenatal carbimazole and choanal atresia: a new embryopathy. Arch Otolaryngol Head Neck Surg 132: 1009-1011.
37. Van Dijke CP, Heydendael RJ, De Kleine MJ, 1987 Methimazole, carbimazole, and congenital skin defects. Ann Int Med 106: 60-61.
38. Di Gianantonio E, Schaefer C, Mastroiacovo PP, et al, 2001 Adverse effects of prenatal methimazole exposure. Teratology 64: 262-266.
39. Barbero P, Valdez R, Rodríguez H, et al, 2008 Choanal atresia associated with maternal hyperthyroidism treated with methimazole: a case-control study. Am J Med Genet A 146A: 2390-2395.
40. Rivkees SA, Mattison DR, 2009 Ending propylthiouracilinduced liver failure in children. N Engl J Med 360: 1574-1575.
41. Rivkees SA, Mattison DR, 2009 Propylthiouracil (PTU) hepatoxicity in children and recommendations for discontinuation of use. Int J Pediatr Endocrinol 2009: 132041.
42. Karras S, Tzotzas T, Krassas GE, 2009 Antithyroid drugs used in the treatment of hyperthyroidism during breast feeding. An update and new perspectives. Hormones 8: 254-257.
43. Rivkees SA, Szarfman A, 2010 Dissimilar hepatotoxicity profiles of propylthiouracil and methimazole in children. J Clin Endocrinol Metab 95: 3260-3267.
44. Rivkees SA,Mattison DR, AACE Patient Safety Editorials Propylthiouracil (PTU) Hepatotoxicity and Graves, Cooper DS, 2009 Disease Therapy. http://www.aacepatientsafetyexchange.com/editorial/index.php?id=25.
45. Bahn RS, Burch HS, Cooper DS, et al, 2009 The role of propylthiouracil in the management of Graves’ disease in adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration. Thyroid 19: 673-674.
46. FDA Statement (Medwatch Online) 2009 Information for healthcare professionals—propylthiouracil-induced liver failure. http://www.fda.gov/Drugs/DrugSafety/ Postmarket DrugSafetyInformationforPatientsandProviders/ DrugSafetyInformationforHeathcareProfessionals/ ucm162701.htm (accessed June 17, 2010)
47. Bulmus N, Ustuner I, Seda Guvendag Guven E, Kir Sahin F, Senturk S, Baydur Sahin S, 2013 Thyroid diseases in pregnancy: The importance of anamnesis. Pak J Med Sci 29: 1187-1192.
48. Medici M, Korevaar TI, Schalekamp-Timmermans S, et al, 2014 Maternal early-pregnancy thyroid function is associated with subsequent hypertensive disorders of pregnancy: the generation R study. J Clin Endocrinol Metab 99: E2591-E2598.
49. Su PY, Huang K, Hao JH, et al, 2011 Maternal thyroid function in the first twenty weeks of pregnancy and subsequent fetal and infant development: a prospective population-based cohort study in China. J Clin Endocrinol Metab 96: 3234-3241.
50. Ashoor G, Maiz N, Rotas M, Kametas NA, Nicolaides KH, 2010 Maternal thyroid function at 11 to 13 weeks of gestation and subsequent development of preeclampsia. Prenat Diagn 30: 1032-1038.
51. Agarwal MM, Dhatt GS, Punnose J, Bishawi B, Zayed R, 2006 Thyroid function abnormalities and antithyroid antibody prevalence in pregnant women at high risk for gestational diabetes mellitus. Gynecol Endocrinol 22: 261-266.
52. Karakosta P, Alegakis D, Georgiou V, et al, 2012 Thyroid dysfunction and autoantibodies in early pregnancy are associated with increased risk of gestational diabetes and adverse birth outcomes. J Clin Endocrinol Metab 97: 4464-4472.
53. Haddow JE, Palomaki GE, Allan WC, et al, 1999 Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. New England Journal of Medicine 341: 549-555.
54. Li Y, Shan Z, Teng W, et al, 2010 Abnormalities of maternal thyroid function during pregnancy affect neuropsychological development of their children at 25-30 months. Clin Endocrinol 72: 825-829.
55. Pop VJ, Kuijpens JL, van Baar AL, et al, 1999 Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin Endocrinol 50: 149-155.
56. Henrichs J, Bongers-Schokking JJ, Schenk JJ, et al, 2010 Maternal thyroid function during early pregnancy and cognitive functioning in early childhood: the generation R study. J Clin Endocrinol Metab 95: 4227-4234.
57. Kooistra L, Crawford S, van Baar AL, Brouwers EP, Pop VJ 2006 Neonatal effects of maternal hypothyroxinemia during early pregnancy. Pediatrics 117: 161-167.
58. Finken MJ, van Eijsden M, Loomans EM, Vrijkotte TG, Rotteveel J, 2013 Maternal hypothyroxinemia in early pregnancy predicts reduced performance in reaction time tests in 5- to 6-year-old offspring. J Clin Endocrinol Metab 98: 1417-1426.
59. Julvez J, Alvarez-Pedrerol M, Rebagliato M, et al, 2012 Thyroxine levels during pregnancy in healthy women and early child neurodevelopment. Epidemiology 24: 150-157.
60. Craig WY, Allan WC, Kloza EM, et al, 2012 Midgestational maternal free thyroxine concentration and offspring neurocognitive development at age two years. J Clin Endocrinol Metab 97: E22-E28.
61. Morreale de Escobar G, Obregón MJ, Escobar del Rey F, 2000 Is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia? J Clin Endocrinol Metab 85: 3975-3987.
62. Berbel P, Mestre JL, Santamaria A, et al, 2009 Delayed neurobehavioral development in children born to pregnant women with mild hypothyroxinemia during the first month of gestation: the importance of early iodine supplementation. Thyroid 19: 511-519.
63. Mannisto T, Mendola P, Reddy U, Laughon SK, 2013 Neonatal outcomes and birth weight in pregnancies complicated by maternal thyroid disease. American J Epidemiol 178: 731-740.
64. Lazarus JH, Bestwick JP, Channon S, et al, 2012 Antenatal thyroid screening and childhood cognitive function. N Engl J Med 366: 493-501.
65. Stagnaro-Green A, Abalovich M, Alexander E, et al, 2011 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 21: 1081-125.
66. Baskin HJ, Cobin RH, Duick DS, et al, 2002 American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract 8: 457-469.
67. ACOG news release 2007 Routine thyroid screening not recommended for pregnant women. www.acog. org/from_home/publications/press_releases/nr10-0107-1.cfm
68. Vaidya B, Anthony S, Bilous M, et al, 2007 Detection of thyroid dysfunction in early pregnancy: universal screening or targeted high-risk case finding? J Clin Endocrinol Metab 92: 203-207.
69. Dosiou C, Sanders GD, Araki SS, Crapo LM, 2008 Screening pregnant women for autoimmune thyroid disease: a cost-effectiveness analysis. Eur J Endocrinol 158: 841-851.
70. Dosiou C, Barnes J, Schwartz A, Negro R, Crapo L, Stagnaro-Green A, 2012 Cost-effectiveness of universal and risk-based screening for autoimmune thyroid disease in pregnant women. J Clin Endocrinol Metab 97: 1536-1546.
71. Haddow JE, McClain MR, Palomaki GE, Kloza EM, Williams J, 2006 Screening for thyroid disorders during pregnancy: results of a survey in Maine. Am J Obstet Gynecol 194: 471-474.
72. Stricker R, Echenard M, Eberhart R, et al, 2007 Evaluation of maternal thyroid function during pregnancy: the importance of using gestational age-specific reference intervals. Eur J Endocrinol 157: 509-514.
73. Panesar NS, Li CY, Rogers MS, 2001 Reference intervals for thyroid hormones in pregnant Chinese women. Ann Clin Biochem 38: 329-332.